Catalyst Clinical Research
Paul Blaney is a seasoned professional in clinical research and project management, currently serving as the Site Head and Director of Business Enablement at Catalyst Clinical Research since February 2018. At Catalyst, Paul is responsible for the identification, implementation, integration, and ongoing development of clinical systems. Prior roles include leadership positions at AstraZeneca, such as Associate Director of Clinical Development and Strategic Enablement Leader in Clinical Operations, where Paul was instrumental in driving process improvement initiatives and overseeing significant clinical trials. Additionally, Paul has extensive experience as a Global Study Manager at Roche Pharmaceuticals, managing phase II and III studies in oncology and infection. Paul holds a Bachelor of Science degree in Chemistry from The University of Sheffield.
This person is not in any teams
This person is not in any offices
Catalyst Clinical Research
2 followers
Catalyst Clinical Research is a provider of clinical operation solutions to the biotechnology, pharmaceutical and medical device companies. The company was built on more than two decades of experience in assisting clients with their clinical development programs by providing therapeutically-aligned experts and teams and customized solutions.